PharmacyCodes



Cefaloglicina [INN-Spanish] en es it fr

Cefaloglicina [INN-Spanish] Brand names, Cefaloglicina [INN-Spanish] Analogs

Cefaloglicina [INN-Spanish] Brand Names Mixture

  • No information avaliable

Cefaloglicina [INN-Spanish] Chemical_Formula

C18H19N3O6S

Cefaloglicina [INN-Spanish] RX_link

No information avaliable

Cefaloglicina [INN-Spanish] fda sheet

Cefaloglicina [INN-Spanish] msds (material safety sheet)

Cefaloglicina [INN-Spanish] Synthesis Reference

No information avaliable

Cefaloglicina [INN-Spanish] Molecular Weight

405.426 g/mol

Cefaloglicina [INN-Spanish] Melting Point

237 oC

Cefaloglicina [INN-Spanish] H2O Solubility

154 mg/L

Cefaloglicina [INN-Spanish] State

Solid

Cefaloglicina [INN-Spanish] LogP

-0.256

Cefaloglicina [INN-Spanish] Dosage Forms

No information avaliable

Cefaloglicina [INN-Spanish] Indication

For treatment of severe infections caused by susceptible bacteria.

Cefaloglicina [INN-Spanish] Pharmacology

Cephaloglycin is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C.

Cefaloglicina [INN-Spanish] Absorption

Well absorbed following oral administration.

Cefaloglicina [INN-Spanish] side effects and Toxicity

Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefaloglicina [INN-Spanish] Patient Information

No information avaliable

Cefaloglicina [INN-Spanish] Organisms Affected

Enteric bacteria and other eubacteria